Dose and fractionation regimens for breast cancer

Lancet Oncology

Volumn 7, Issue 8, 2006, Pages 617-

  Munshi, Anusheel ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSIMETRY; HEART DISEASE; HUMAN; LETTER; LUNG DISEASE; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; FEMALE; NOTE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL;

BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS;

EID: 33746389334     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70772-0     Document Type: Letter

References (4)

1. Owen J., Ashton A., Bliss J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
2. Touboul E., Belkacemi Y., Lefranc J., et al. Early breast cancer: influence of type of boost (electrons vs iridium-192) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 34 (1995) 105-113
3. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000) 1757-1770
4. Thames H., Bentzen S., Turesson I., et al. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol 19 (1990) 219-235